Compare Novartis AG (NVS) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Pinterest Inc — how do they compare? Novartis AG trades at $142.98 (market cap $268.57B), while Pinterest Inc trades at $20.6 (market cap $11.63B). The key difference: Novartis AG is far larger — about 23.1× Pinterest Inc's market cap, and Novartis AG pays a 3.31% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and Pinterest Inc for 85 Days on average.
| NVS | PINS | |
|---|---|---|
Market Cap | $268.57B | $11.63B |
Volume | 1,532,573 | 12,792,940 |
Sector | Health | Media |
52-Week High | $168.62 | $35.24 |
52-Week Low | $121.80 | $15.42 |
Typical Hold Time | 82 Days | 85 Days |
Enterprise Value | $309.89B | $11.55B |
Dividend Yield | 3.31% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.28, up 1.77% on the day, with a neutral technical signal and mixed earnings history. The company reported strong 2025 revenue of $56.67B and a net income margin of 22.5%, supported by a recent $7.8B licensing deal with China's Abogen. However, recent clinical trial setbacks and an ongoing law firm investigation introduce uncertainty.
The outlook is balanced; solid profitability and a consensus price target of $146.00 suggest modest upside, but risks from pipeline failures and heightened M&A scrutiny warrant caution. Investor sentiment is mixed, with analysts predominantly holding a neutral stance amid evolving business developments.
Pinterest (PINS) trades at $20.31, up 1.4% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue growth accelerated to $4.22 billion in 2025, with a net income margin of 9.87%, while analyst consensus is a Buy with a $27.93 price target. Recent news highlights its undervaluation and new Visual Search Ads launch, though insider selling and cash flow volatility present mixed signals.
The outlook is positive given robust fundamentals and growth potential, but risks include competitive pressures and reliance on ad revenue. Upside is supported by earnings momentum and international monetization, yet investors should monitor cash flow trends and market sentiment shifts for sustained gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
